Kathleen Veit
Senior Vice President, Global Compliance & Ethics Officer
Kathleen Veit was appointed Senior Vice President, Global Compliance & Ethics Officer in July 2022 to oversee regulatory and business driven compliance strategy, lead the global compliance & ethics program and engage the organization in promoting a culture of compliance based on company values and Code of Conduct.
Teva’s Global Compliance & Ethics team is tasked with providing risk-based strategy, standards, processes and policies to drive a comprehensive compliance framework across the organization. This framework is based on laws, regulations, industry standards and company Code of Conduct, laying the foundation to support a strong culture of compliance and Integrity throughout the organization.
Prior to joining Teva in 2010, Kate held related leadership roles at Merck, Novartis, Cigna, and Dow Chemical.
Kate holds a Bachelor of Science Degree in Criminal Justice from West Chester University and Master of Arts Degree in Education/Program Administration from Seton Hall University.
Richard Francis
President and Chief Executive Officer, Member of the Board of Directors
Richard Daniell
Executive Vice President, European Commercial
Christine Fox
Executive Vice President, U.S. Commercial
Angus J. Grant, PhD
Executive Vice President, Business Development
Dr. Eric A. Hughes
Executive Vice President, Global R&D and Chief Medical Officer
Placid Jover
Executive Vice President, Chief Human Resources Officer
Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)
David McAvoy
Executive Vice President, Chief Legal Officer
Mark Sabag
Executive Vice President, International Markets Commercial
Matthew Shields
Executive Vice President, Teva Global Operations
Nir Baron
Senior Vice President, Chief Internal Auditor
